Findings from a new study led by Yale Cancer Center show the small molecule inhibitor drug, PF05175157, originally developed to treat diabetes by Pfizer, may help in the treatment of breast cancer.
from News Medical Medical Research News Feed https://ift.tt/3yqPmrV
0 Comments